These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8039040)

  • 1. Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure.
    Liou HH; Chiang SS; Wu SC; Yang WC; Huang TP
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 May; 53(5):276-81. PubMed ID: 8039040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study.
    Liou HH; Chiang SS; Wu SC; Huang TP; Campese VM; Smogorzewski M; Yang WC
    Am J Kidney Dis; 1994 Feb; 23(2):266-71. PubMed ID: 8311086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches.
    Ngugi NN; McLigeyo SO; Kayima JK
    East Afr Med J; 1997 Aug; 74(8):503-9. PubMed ID: 9487416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe?
    Mandelberg A; Krupnik Z; Houri S; Smetana S; Gilad E; Matas Z; Priel IE
    Chest; 1999 Mar; 115(3):617-22. PubMed ID: 10084465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients.
    Mahajan SK; Mangla M; Kishore K
    J Assoc Physicians India; 2001 Nov; 49():1082-5. PubMed ID: 11868861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potassium-lowering effect of albuterol for hyperkalemia in renal failure.
    Montoliu J; Lens XM; Revert L
    Arch Intern Med; 1987 Apr; 147(4):713-7. PubMed ID: 3827459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta(2)-adrenergic agonist (salbutamol) in chronic renal failure patients.
    Kim HJ
    J Korean Med Sci; 1997 Apr; 12(2):111-6. PubMed ID: 9170015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correction of hyperkalemia with intravenous salbutamol in children with chronic renal insufficiency].
    Arias-Reyes JA; Matos-Martínez M; Velásquez-Jones L; Dubey-Ortega LA
    Bol Med Hosp Infant Mex; 1989 Sep; 46(9):603-6. PubMed ID: 2604875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hyperkalaemia using intravenous and nebulised salbutamol.
    McClure RJ; Prasad VK; Brocklebank JT
    Arch Dis Child; 1994 Feb; 70(2):126-8. PubMed ID: 8129434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of hyperkalemia in dialysis patients.
    Putcha N; Allon M
    Semin Dial; 2007; 20(5):431-9. PubMed ID: 17897250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rapid correction of acute hyperkalemia with nebulized salbutamol].
    Leanza HJ; Rivarola G; Graciela García M; Najun Zarazaga CJ; Casadei D
    Medicina (B Aires); 1992; 52(2):99-102. PubMed ID: 1308916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperkalemia: therapeutic options in acute and chronic renal failure.
    Kemper MJ; Harps E; Müller-Wiefel DE
    Clin Nephrol; 1996 Jul; 46(1):67-9. PubMed ID: 8832156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaler salbutamol for acute hyperkalemia in renal failure.
    Mocan MZ; Mocan G; Mocan H; Gorçin B
    Isr J Med Sci; 1993 Jan; 29(1):39-41. PubMed ID: 8454446
    [No Abstract]   [Full Text] [Related]  

  • 14. Nebulized salbutamol diminish the blood glucose fluctuation in the treatment of non-oliguric hyperkalemia of premature infants.
    Saw HP; Chiu CD; Chiu YP; Ji HR; Chen JY
    J Chin Med Assoc; 2019 Jan; 82(1):55-59. PubMed ID: 30839405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients.
    Kim HJ
    Nephron; 1996; 72(3):476-82. PubMed ID: 8852501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new treatment of hyperkalemia in renal failure with selective beta 2-adrenergic stimulant, terbutaline sulfate].
    Tanaka Y; Nagao M; Nishio T; Hashida E; Kashiwagi A; Shigeta Y
    Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):353-8. PubMed ID: 2747008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hyperkalaemia in renal failure with salbutamol inhalation.
    Montoliu J; Almirall J; Ponz E; Campistol JM; Revert L
    J Intern Med; 1990 Jul; 228(1):35-7. PubMed ID: 2384735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol.
    Allon M; Shanklin N
    Am J Kidney Dis; 1996 Oct; 28(4):508-14. PubMed ID: 8840939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of salbutamol in the treatment of severe hyperkalemia in hemodialysed patients].
    de Cornelissen F; Bermudes H; Saint-Loubert M; Marty L; Emond C; Fontanier P
    Presse Med; 1989 Jun; 18(25):1243-4. PubMed ID: 2525773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hyperkalaemia in renal failure: salbutamol v. insulin.
    Lens XM; Montoliu J; Cases A; Campistol JM; Revert L
    Nephrol Dial Transplant; 1989; 4(3):228-32. PubMed ID: 2498781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.